Multimodal Magnetic Resonance Imaging for Evaluating Hypoxic-Ischemic Encephalopathy in Neonates

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054045

Enrollment

Unknown

Registered

2021-12-07

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxic-ischemic encephalopathy

Interventions

Gold Standard:Obstetric history and neurological symptoms during the neonatal period are often considered the diagnostic reference standard for hypoxic-ischemic encephalopathy. Blood biochemical exami

Index test:Multimodal&#32

Magnetic&#32

Resonance&#32

imaging

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children who were clinically suspected of hypoxic ischemic encephalopathy during the study period and underwent head MRI examination in our hospital.

Exclusion criteria

Exclusion criteria: The family gave up the treatment; the family requested to withdraw from the study.

Design outcomes

Primary

Measure	Time frame
creatine phosphate kinase;lactate dehydrogenase;Mean transit time;aspartate aminotransferase;	—

Countries

China

Contacts

Public ContactLiu Bo

Children's Hospital of Chongqing Medical University

sccdxdlb@163.com+86 13996236754

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026